Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Patient Empowerment: later-stage trial registry

1 of 5 indexed Patient Empowerment trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Patient Empowerment: 5 US clinical trials tracked, 1 recruiting.

Patient Empowerment is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Tufts Medical Center, running 1 of these trials.

Enrollment posture brief

Registry condition patient-empowerment

OPEN 1 | RECR 20% | LATE 1 | EARLY 0 | RANK #3391 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Patient Empowerment (this)20%
Open-enrollment share among volume-matched conditions near Patient Empowerment

Patient Empowerment lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Patient Empowerment on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Patient Empowerment is recruiting below its size-band peers.

    1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Patient Empowerment research.

    Tufts Medical Center accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Patient Empowerment enrolment sits around 163 participants.

    Median target enrolment is 163 among the 5 trials that report a genuine target (sentinel values excluded). 1 of those (20%) plan for fewer than 100 participants.

  4. Patient Empowerment research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Patient Empowerment records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Period Kit Other
1 trials
Patient partnership tools Other
1 trials
6 Minute Walk Test (6MWT) Other
1 trials
Hugo Health ("Hugo") Other
1 trials
Baseline Survey Clinician- reported (ClinRO) ECOG Other
1 trials
PRO Instruments assessment questionnaire Other
1 trials
Opioid destruction education Behavioral
1 trials
Pelvic wand Device
1 trials

US sites by state

Facility locations filed on Patient Empowerment trials. A trial with sites in several states counts in each.

Massachusetts 2 trials
Texas 1 trials
Nebraska 1 trials
Minnesota 1 trials
Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Patient Empowerment page

5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Patient Empowerment condition card totals 5 registered trials; most-linked intervention Period Kit; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.